REFERENCES
- Ashley-Koch A, Yang Q, Olney RS. (1999). American Journal of Epidemiology, 51, 839–845.
- Bon B, Houze S, Talabani H, Magne D, Belkadi G, Develoux M, Senghor Y, Chandenier J, Ancelle T, Hennequin C. (2010). Journal of Clinical Microbiology, 48, 1716–1719.
- Canalli AA, Conran N, Fattori A, Saad STO, Ferreira Costa F. (2004). Experimental Hematology, 32, 728–734.
- Dreyer G, Fernandes-Silva E, Alves S, Rocha A, Albuquerque R, Addiss D. (1996). Journal of Clinical Microbiology, 34, 2569–2571.
- Gam AA, Neva FA, Krotoski WA. (1982). American Journal of Tropical Medicine and Hygiene, 37, 157–161.
- Gann PH, Neva FA, Gam AA. (1994). Journal of Infectious Diseases, 169, 1076–1079.
- Genta RM. (1989). Review of Infectious Diseases, 11, 755–767.
- Hamilton JA. (2002). Trends in Immunology, 23, 403–408.
- Hebbel RP. (1997). The Journal of Clinical Investigation, 99, 2561–2564.
- Herbert DR, Lee JJ, Lee NA, Nolan TJ, Schad DA. (2000). The Journal of Immunology, 165, 4544–4451.
- Marcos LA, Terashima A, Dupont HL, Gotuzzo E. (2008). Transactions of Royal Society of Tropical Medicine and Hygiene, 102, 314–318.
- Rotman HL, Yutanawiboonchai W, Brigandi RA, Leon O, Gleich GJ, Nolan TJ. (1996). Experimental Parasitology, 82, 267–278.
- Sarroll SM, Karthiagsu KT, Grove DI. (1981). Transactions of Royal Society of Tropical Medicine and Hygiene, 75, 706–709.
- Segarra-Newnham M. (2007). The Annals of Pharmacotherapy, 41, 1992–2001.
- Siddiqui AA, Berk SL. (2001). Clinical Infectious Diseases, 33, 1040–1047.
- Sodipo JOA, Padgett D, Warrie E, Olopoenia L. (1997). Journal of the National Medical Association, 89, 285–288.
- Urban J.F., Madden K.B, Svetic A., Cheever A., Trotta PP, Gause WC. (1992). Immunological Reviews, 127, 205–220.
- WOG. (2004). WGO Practice Guideline Management of Strongyloidiasis. Milwaukee, WI: WGO.
- Zangrilli JG. (2002). American Journal of Respiratory Cell and Molecular Biology, 26, 388–390.